This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Laven, D. L. Articles by Bednarczyk, E. M. Search for Related Content Social Bookmarking                         What's this?

CNS Assessment Using Functional Neuro-PET Imaging

Gammascan Consultants, 633 Sabal Lake Drive (Unit 103), Longwood, Florida 32779, dlavenrx{at}earthlink.net

Edward M. Bednarczyk

Department of Nuclear Medicine, University at Buffalo-State University of New York, Parker Hall (Rm 105), 3435 Main Street, Buffalo, New York 14214-3007

Disorders of the brain manifest in a variety of manners ranging from feeling or thought abnormalities to total paralysis. Until recently, most imaging methods of the brain have been limited to anatomic considerations, with little information about actual function of the brain except that deduced from clinical examination and physical and cognitive assessment testing. With the advent of positron emission tomography (PET) and enhanced computer and scintigraphic image detection systems, there is keen interest in applying this imaging technique to better understand brain physiology and pathophysiology. Potential applications of PET in CNS assessment is expanding avenues for improved diagnosis and staging of disease, as well as monitoring therapeutic interventions. A general review of the radiopharmaceuticals used for neuro-PET imaging, as well as their application in situations such as cerebrovascular disease, brain activation studies, various movement disorders and dementias, depression, epilepsy, obsessive-compulsive disorder, schizophrenia, and neuropharmacology (including cerebral receptor studies) will be presented.

Key Words: positron emission tomography • neuropharmacology • depression • obsessive-compulsive disorder • Alzheimer’s disease • Parkinson’s disease • schizophrenia • cerebrovascular disease • dementia • epilepsy

Journal of Pharmacy Practice, Vol. 14, No. 4, 308-331 (2001)
DOI: 10.1106/HA45-0VJG-R5BV-XBUB


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?